Hem › Burkitts lymfom › Colorado › Aurora

Kliniska studier för Burkitts lymfom i Aurora, CO

10 studier för Burkitts lymfom söker deltagare vid platser i och runt Aurora (inom ca 30 miles). Öppna en studie för att se vem som kan delta och hur du kontaktar studieteamet.

Officiell studietext (engelska)

Rekryterar du till en studie? Visa den högst upp på sidan – $99 i 30 dagar →

A Study Testing the Combination of Dasatinib or Imatinib to Chemotherapy Treatment With Blinatumomab for Children, Adolescents, and Young Adults With Philadelphia Chromosome Positive (Ph+) or ABL-Class Philadelphia Chromosome-Like (Ph-Like) B-cell Acute Lymphoblastic Leukemia (B-ALL)

RekryterarFas 2

Children's Hospital Colorado, Aurora

366 Days – 46 Years · Alla kön · Uppdaterad 2 okt. 2026 · NCT06124157

Pharmacokinetic Study of Venetoclax Tablets Crushed and Dissolved Into a Solution

RekryterarObservationsstudie

Children's Hospital Colorado, Aurora

Ålder 0 till 38 · Alla kön · Uppdaterad 1 okt. 2026 · NCT06131801

Testing the Addition of the Anti-cancer Drug Venetoclax and/or the Anti-cancer Immunotherapy Blinatumomab to the Usual Chemotherapy Treatment for Infants With Newly Diagnosed KMT2A-rearranged or KMT2A-non-rearranged Leukemia

RekryterarFas 2

Children's Hospital Colorado, Aurora

365 Days · Alla kön · Uppdaterad 25 sep. 2026 · NCT06317662

Substudy 01A: Zilovertamab Vedotin in Pediatric and Young Adult Participants With Hematologic Malignancies or Solid Tumors (MK-9999-01A/LIGHTBEAM-U01)

RekryterarFas 1/2

Children's Hospital Colorado-Center for Cancer and Blood Disorders ( Site 1016), Aurora

6 Months – 25 Years · Alla kön · Uppdaterad 17 sep. 2026 · NCT06395103

UCD19 CarT in Treatment of Pediatric B-ALL and B-NHL

RekryterarFas 1/2

Children's Hospital Colorado, Aurora

31 Days – 30 Years · Alla kön · Uppdaterad 14 sep. 2026 · NCT04544592

A Study to Compare Blinatumomab Alone to Blinatumomab With Nivolumab in Patients Diagnosed With First Relapse B-Cell Acute Lymphoblastic Leukemia (B-ALL)

RekryterarFas 2

Children's Hospital Colorado, Aurora

Ålder 1 till 30 · Alla kön · Uppdaterad 1 sep. 2026 · NCT04546399

Inotuzumab Ozogamicin and Post-Induction Chemotherapy in Treating Patients With High-Risk B-ALL, Mixed Phenotype Acute Leukemia, and B-LLy

RekryterarFas 3

Children's Hospital Colorado, Aurora

365 Days – 25 Years · Alla kön · Uppdaterad 25 aug. 2026 · NCT03959085

CD19x22 Chimeric Antigen Receptor T-cell Therapy (CAR T) in Pediatric B-ALL

RekryterarFas 1

Children's Hospital Colorado, Aurora

3 Months – 30 Years · Alla kön · Uppdaterad 28 nov. 2025 · NCT06559189

Phase 1/2 Study of UCART22 in Patients With Relapsed or Refractory CD22+ B-cell Acute Lymphoblastic Leukemia (BALLI-01)

RekryterarFas 1/2

University of Colorado - Aurora Cancer Center, Aurora

Ålder 15 till 50 · Alla kön · Uppdaterad 9 sep. 2025 · NCT04150497

The EndRAD Trial: Eliminating Total Body Irradiation (TBI) for NGS-MRD Negative Children, Adolescents, and Young Adults With B-ALL

RekryterarFas 2

Children's Hospital Colorado, Aurora

Ålder 1 till 25 · Alla kön · Uppdaterad 4 maj 2025 · NCT03509961

Burkitts lymfom-studier i andra städer

Andra studier i Aurora

Från ClinicalTrials.gov, data hämtad 5 okt. 2026. Varje studie har egna kvalifikationskrav; studieteamet avgör vem som kan delta.